Viewing StudyNCT06466525



Ignite Creation Date: 2024-07-17 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 3:32 PM
Study NCT ID: NCT06466525
Status: RECRUITING
Last Update Posted: 2024-06-20
First Post: 2024-06-10

Brief Title: A Two-Part Single and Multiple Ascending Dose Trial of the Safety Tolerability Pharmacokinetics and Pharmacodynamics of LBT-3627 in Healthy Participants and in Participants With Parkinsons Disease
Sponsor: Longevity Biotech Australia Pty Ltd subsidiary
Organization: Longevity Biotech

Conditions & Keywords Data

Conditions:
Name
Parkinson Disease
Keywords: